coproporphyrin i has been researched along with Breast Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, IT; Cheeti, S; Chen, B; Cheung, KWK; Liu, L; Morley, R; Sahasranaman, S; Yoshida, K | 1 |
1 trial(s) available for coproporphyrin i and Breast Neoplasms
Article | Year |
---|---|
GDC-0810 Pharmacokinetics and Transporter-Mediated Drug Interaction Evaluation with an Endogenous Biomarker in the First-in-Human, Dose Escalation Study.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Biomarkers; Breast Neoplasms; Cinnamates; Coproporphyrins; Dose-Response Relationship, Drug; Drug Interactions; Feasibility Studies; Female; Half-Life; Humans; Indazoles; Liver-Specific Organic Anion Transporter 1; Middle Aged; Receptors, Estrogen; Solute Carrier Organic Anion Transporter Family Member 1B3 | 2019 |